Hemostatic Disorders Associated with Hepatobiliary Disease.

Area of Science:

• Veterinary Medicine
• Hepatology
• Hemostasis

Background:

• The liver is central to hemostasis, producing and clearing key coagulation factors.
• Hepatobiliary disease can disrupt normal coagulation, presenting diagnostic challenges.
• Coagulation abnormalities in liver disease range from hypocoagulability to hypercoagulability.

Purpose of the Study:

• To summarize coagulation abnormalities in dogs and cats with hepatobiliary disease.
• To provide practical strategies for managing bleeding and thrombotic risks.
• To highlight the complexity of coagulation in veterinary liver disease.

Main Methods:

• Literature review of reported coagulation abnormalities in dogs and cats with hepatobiliary disease.
• Synthesis of findings regarding procoagulation, anticoagulation, and fibrinolysis.
• Development of clinical management strategies based on current evidence.

Main Results:

• Hepatobiliary disease is associated with a wide spectrum of coagulation dysfunctions.
• Both bleeding tendencies and thrombotic events are reported in affected animals.
• Coagulation status can be unpredictable and requires careful monitoring.

Conclusions:

• Veterinary patients with hepatobiliary disease exhibit complex and varied coagulation profiles.
• Proactive management strategies are essential to address both hemorrhage and thrombosis.
• Further research is needed to fully elucidate the mechanisms and optimal treatment of coagulation disorders in liver disease.